Sana Biotechnology Inc. (NASDAQ:SANA) is one of the most promising penny stocks under $5 to buy. On February 17, Sana ...
Vertex has continued to deliver breakthrough drugs for cystic fibrosis while exploring treatments for other illnesses ...
The deal builds on a 2022 collaboration between Arcellx and Kite, a Gilead company, and eliminates profit-sharing and milestone structures, consolidating economics under Gilead as it deepens its ...
Experts discuss biotechnology's role in advancing personalized medicine at a VIT webinar, highlighting career opportunities ...
Add Yahoo as a preferred source to see more of our stories on Google. Lululemon launched its first product using plant-based nylon in April 2023 Biotechnology is the exploitation of biological ...
Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor ...
Astellas Pharma Inc. and Vir Biotechnology, Inc. have entered into a global strategic collaboration to advance VIR-5500, an ...
Carnegie Mellon University and the University of Pittsburgh offered rare looks Thursday into two cutting-edge research ...
Dallas Entrepreneur Launches $1,000 Andrew Hillman Biotech Grant for Undergraduates DALLAS, TX, UNITED STATES, February ...
The consensus estimate for Q4 2025 revenue is $23.18 million, and the earnings are expected to come in at -$0.41 per share. The full year 2025's revenue is expected to be $19.22 million, and the ...
Apogee Therapeutics (NASDAQ: APGE) is one of the 17 biotechnology stocks with more than 50% upside. On January 25, Citi analyst Geoff Meacham maintained a Buy rating on Apogee Therapeutics ...
The Department of Biotechnology, under the Ministry of Science and Technology has released notification for the Scientist 'C' posts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results